Why the study?
Does widespread vaccination with conjugate Haemophilus influenzae type b vaccines reduce oropharyngeal carriage of Hib in children aged 2 to 5 years?
Does widespread vaccination with conjugate Haemophilus influenzae type b vaccines reduce oropharyngeal carriage of Hib in children aged 2 to 5 years?
Widespread use of conjugate Hib vaccines is associated with a very low rate of Hib oropharyngeal carriage (0.17%) in children, likely contributing to the decline in invasive Hib disease.
Answers are grounded in this paper and cite their sources.
Supports conjugate Hib vaccination reducing carriage; leaves open confirmation of impact on invasive disease.
Rates of invasive Haemophilus influenzae type b (Hib) disease in children decreased very rapidly after licensure of Hib conjugate vaccines. A role for a vaccine-related reduction in nasopharyngeal carriage of Hib has been suggested. We studied oropharyngeal carriage of Hib and vaccination rates in a population of 2- to 5-year-old children in metropolitan Atlanta. Among 584 children 75% were vaccinated with an Hib conjugate vaccine, 17% had not been vaccinated and 8% had no vaccination records available. Forty-one percent of the children were colonized with H. influenzae. One child was colonized with Hib. Hib carriage (0.17%; upper 95% confidence interval boundary, 0.97%) was substantially lower than the estimates of Hib carriage from prior studies of children who had not received Hib conjugate vaccines. Our data are consistent with a decline in Hib carriage induced by widespread use of conjugate Hib vaccines, which may have contributed to the decline of Hib disease in United States children.
No takes yet. Share an insight, caveat, or question.
Mohle‐Boetani et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: